Nanoveu Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Nanoveu şirketinin toplam hissedar öz sermayesi A$886.9K ve toplam borcu A$0.0 olup, bu da borç-öz sermaye oranını 0% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla A$1.7M ve A$815.6K dir.

Anahtar bilgiler

Borç/özkaynak oranı

AU$0

Borç

Faiz karşılama oranı	n/a
Nakit	AU$1.16m
Eşitlik	AU$886.91k
Toplam yükümlülükler	AU$815.58k
Toplam varlıklar	AU$1.70m

Son finansal sağlık güncellemeleri

Here's Why We're Watching Nanoveu's (ASX:NVU) Cash Burn Situation

Oct 23

Recent updates

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: NVU 'nin kısa vadeli varlıkları ( A$1.6M ) kısa vadeli yükümlülüklerini ( A$815.6K ) aşıyor.

Uzun Vadeli Yükümlülükler: NVU un uzun vadeli yükümlülüğü bulunmamaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: NVU borçsuzdur.

Borcun Azaltılması: NVU un 5 yıl önce borcu yoktu.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: NVU şirketinin mevcut serbest nakit akışına göre bir yıldan az nakit akışı süresi bulunmaktadır.

Tahmini Nakit Akışı: Serbest nakit akışı her yıl % 7.6 oranında tarihsel oranda büyümeye devam ederse NVU un bir yıldan az nakit akışı süresi vardır.

Nanoveu Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Here's Why We're Watching Nanoveu's (ASX:NVU) Cash Burn Situation

Recent updates

Here's Why We're Watching Nanoveu's (ASX:NVU) Cash Burn Situation

Nanoveu Limited (ASX:NVU) signed a letter of intent to acquire Embedded A.I. Systems Pte Ltd for AUD 1.9 million.

We Think The Compensation For Nanoveu Limited's (ASX:NVU) CEO Looks About Right

Nanoveu Limited, Annual General Meeting, May 31, 2024

Less than half of directors are independent

Nanoveu Limited has completed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Nanoveu Limited has filed a Follow-on Equity Offering in the amount of AUD 0.6 million.

Nanoveu Limited Announces Change of Chief Financial Officer

Nanoveu Limited Announces Change of Chief Financial Officer

Nanoveu Limited, Annual General Meeting, May 31, 2023

Full year 2022 earnings released: AU$0.012 loss per share (vs AU$0.013 loss in FY 2021)

Nanoveu Limited Appoints David Pevcic as Director and Non-Executive Chairman

Less than half of directors are independent

Less than half of directors are independent

First half 2022 earnings released: AU$0.006 loss per share (vs AU$0.007 loss in 1H 2021)

Nanoveu Limited Announces Resignation of Mr. Scott Beeton as A Director Effective 31 August 2022

Insider recently bought AU$367k worth of stock

Nanoveu Limited, Annual General Meeting, May 31, 2022

Less than half of directors are independent

Nanoveu Limited Receives Approval for the Registration of its Nanoshield Film Line

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Nanoveu Limited Announces Retirement of David Nicol as Director

Nanoveu Limited Launches Spray Coating Effective Against MHV-A59

Nanoveu Limited announced that it expects to receive AUD 1.35 million in funding

Nanoveu Limited (ASX:NVU): When Will It Breakeven?

Nanoveu Limited Launches Product Development Update and Outdoor Test Results

Nanoveu Limited Executes A 12-Month Exclusive Distribution Agreement (The Agreement) with Cuvira Limited (Cuvira)

Nanoveu Limited announced that it expects to receive AUD 0.66 million in funding

Nanoveu Limited Announces Advanced Prototype of EyeFyx Product

Nanoveu Limited Secures New Sales for its B2B Antiviral Film and Antiviral Mobile Phone Protection Product

Nanoveu Limited announced that it expects to receive AUD 2.4 million in funding from Antiviral technologies portfolio LLC

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin